Seminars in Nephrology
Volume 24, Issue 3 , Pages 256-268 , May 2004

Clinical presentation, natural history, and treatment of crescentic proliferative IgA nephropathy

  • James A Tumlin

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Dr. James A. Tumlin, Emory University School of Medicine, Renal Division, 1364 Clifton Rd., NE, Atlanta, GA 30322, USA
    • Division Nephrology and the Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, USA
    • ,
  • R.A Hennigar

      Affiliations

    • Division Nephrology and the Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, USA

References 

  1. Kobayashi Y, Fujii K, Hiki Y, Tateno S. Steroid therapy in IgA nephropathy (a prospective pilot study in moderate proteinuric cases). Q J Med. 1986;61:935–943
  2. Haas M. Histological subclassification of IgA Nephropathy (A clinicopathologic study of 244 cases). Am J Kidney Dis. 1997;29:829–842
  3. Floege J, Feehally J. IgA nephropathy (Recent developments). J Am Soc Nephrol. 2000;11:2395–2403
  4. Nicholls K, Walker R, Dowling J, Kincaid-Smith P. “Malignant” IgA nephropathy. Am J Kidney Dis. 1985;5:42–46
  5. Welch TR, McAdams AJ, Berry A. Rapidly progressing IgA nephropathy. Am J Dis Child. 1988;142:789–793
  6. Subias R, Botey A, Darnell A, Montoliu J, Revert L. Malignant or accelerated hypertension in IgA nephropathy. Clin Nephrol. 1987;27:1–7
  7. Abe T, Kida H, Yshimura H, Koshino Y, Tomosugi N, Hattori N. Participation of extracapillary lesions (ECL) in progression of IgA nephropathy. Clin Nephrol. 1986;25:37–41
  8. Ferrario F, Napodano P, Rastaldi M, D’Amico G. Capillaritis in IgA nephropathy. Contrib Nephrol. 1995;111:8–12
  9. D’Amico G, Napodano P, Ferrario F, Rastaldi MP, Arrigo G. Idiopathic IgA nephropathy with segmental necrotizing lesions of the capillary wall. Kidney Int. 2001;59:682–692
  10. Widstam-Attorps U, Berg U, Bohman S, Lefvert A. Proteinuria and renal function in relation to renal morphology. Clin Nephrol. 1992;38:245–253
  11. D’Amico G, Minetti L, Ponticelli C, et al.  Prognostic indicators in idiopathic IgA mesangial nephropathy. Q J Med. 1986;59:363–378
  12. Alamartine E, Sabatier J, Guerin C, Baerliet J, Berthoux F. Prognostic factors in mesangial IgA glomerulonephritis (An extensive study with univariate and multivariate analyses). Am J Kidney Dis. 1991;18:12–19
  13. Boyce NW, Holdsworth SR, Thomson NM, Atkins RC. Clinicopathological associations in mesangial IgA nephropathy. Am J Nephrol. 1986;6:246–252
  14. Tumlin JA, Lohavichan V, Hennigar R. Crescentic proliferative IgA nephropathy (Clinical and histologic response to methyl prednisolone and intravenous cyclophosphamide). Nephrol Dial Transplant. 2003;18:1321–1328
  15. D’Amico G. Natural history of idiopathic IgA nephropathy (Role of clinical and histological prognostic factors). Am J Kidney Dis. 2001;36:227–237
  16. Shouno Y, Shimokama T, Sakemi T, Harada A, Yamaguchi M, Wantanabe T. Segmental glomerular necrosis as an active index of IgA nephropathy (A study with 100 serial sections of 128 cases). Acta Pathol Jpn. 1993;43:723–729
  17. Hogg RJ, Silva FG, Wyatt RJ, Reisch JS, Argyle JC, Savino DA. Prognostic indicators in children with IgA nephropathy (Report of the Southwest Pediatric Nephrology Study Group). Pediatr Nephrol. 1994;8:15–20
  18. Pozzi C, Bolasco P, Fogazzi G, et al.  Corticosteroids in IgA nephropathy (A randomized controlled trial). Lancet. 1999;353:883–887
  19. Waldo FB, Wyatt RJ, Kelly DR, Herrera GA, Benfiled MR, Kohaut EC. Treatment of IgA nephropathy in children (Efficacy of alternate day oral prednisone). Pediatr Nephrol. 1993;7:529–532
  20. Lai K, Lai F, Ho C, Chan W. Corticosteroid therapy in IgA nephropathy with nephrotic syndrome (A long-term controlled trial). Clin Nephrol. 1986;26:174–180
  21. Hotta O, Furuta T, Chiba S, Tomioka S, Toguma Y. Regression of IgA. Regression of IgA nephropathy: a biopsy study. Am J Kidney Dis. 2002;39:493–502
  22. Ballardie FW, Roberts ISD. Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy. J Am Soc Nephrol. 2002;13:142–148
  23. McIntyre CW, Fluck RJ, Lambie SH. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescentic change (An effective treatment). Clin Nephrol. 2001;56:193–198
  24. D’Amico G. The commonest glomerulonephritis in the world (IgA nephropathy). Q J Med. 2001;64:709–727

PII: S0270-9295(04)00008-7

doi: 10.1016/j.semnephrol.2004.01.006

Seminars in Nephrology
Volume 24, Issue 3 , Pages 256-268 , May 2004

Article Tools

* Image Usage & Resolution